12:00 AM
 | 
Jul 15, 2013
 |  BC Week In Review  |  Company News  |  Sales & Marketing

Seegene, Eisai sales and marketing update

Seegene granted Eisai's in vitro diagnostic subsidiary, Eidia Co. Ltd., exclusive rights to market Seegene's TOCE technology-based multiplexed molecular...

Read the full 74 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$30 USD
More Info >